"Analysis.group","Analysis.number","Analysis.name","Subgroup","Subgroup.number","Applicability","Study","Study.year","GIV.Mean","GIV.SE","Experimental.mean","Experimental.SD","Experimental.cases","Experimental.N","Control.mean","Control.SD","Control.cases","Control.N","O.E","Variance","Weight","Mean","CI.start","CI.end","Footnotes","Bias.arising.from.the.randomization.process.judgement","Bias.arising.from.the.randomization.process.support","Bias.due.to.deviations.from.intended.interventions.judgement","Bias.due.to.deviations.from.intended.interventions.support","Bias.due.to.missing.outcome.data.judgement","Bias.due.to.missing.outcome.data.support","Bias.in.measurement.of.the.outcome.judgement","Bias.in.measurement.of.the.outcome.support","Bias.in.selection.of.the.reported.result.judgement","Bias.in.selection.of.the.reported.result.support","Overall.bias.judgement","Overall.bias.support","review.url","review.doi","analysis_key","dataset_name","mismatch_type","direction_match","or_sig","rd_sig","log_or","rd","log_or_ci_lb","log_or_ci_ub","rd_ci_lb","rd_ci_ub","sparse_events","double_zero"
1,10,"Hip circumference (cm) (10 to 19 years)",NA,NA,"SUBGROUP_AND_OVERALL","Gobel 2012",2012,NA,NA,-0.09,13.35411173,NA,27,1.6,8.344746851,NA,23,NA,NA,100,-1.69,-7.772997,4.392997,NA,"Low risk","<p>Randomly assigned using computer-generated numbers. Randomisation sequence not revealed to the participants. </p>",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015875/full","10.1002/14651858.CD015875","10::overall","CD015875_data","direction_only",FALSE,FALSE,FALSE,-0.209872273568972,0.00279805291213443,-1.13270295225696,0.712958405119019,-0.0879210434048784,0.0935171492291473,TRUE,FALSE
2,10,"Metabolic syndrome (10 to 19 years) ",NA,NA,"SUBGROUP_AND_OVERALL","Leong 2020",2021,NA,NA,NA,NA,9,35,NA,NA,13,40,NA,NA,100,0.718935,0.262858,1.966336,NA,"Low risk","<p>An independent researcher performed group allocation in 3 steps: (1) participant allocation to group A or B using the randomisation sequence; (2) obtaining the capsule packs (independently labeled A or B by a technician); and (3) allocation of capsule packs to participants according to their unique code. No difference between the groups at baseline.</p>",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015875/full","10.1002/14651858.CD015875","10::overall","CD015875_data","direction_only",FALSE,FALSE,FALSE,-0.209872273568972,0.00279805291213443,-1.13270295225696,0.712958405119019,-0.0879210434048784,0.0935171492291473,TRUE,FALSE
4,10,"Adverse events: abdominal pain (0 to 19 years)",NA,NA,"SUBGROUP_AND_OVERALL","Fonvig 2021",2021,NA,NA,NA,NA,3,50,NA,NA,1,25,NA,NA,100,1.531915,0.151154,15.525646,NA,"Low risk","<p>Participants were randomised using a computer-generated list developed by HB Medical, Horsholm, Denmark. Two complete sets of randomisation code envelopes were provided, kept, sealed, and were accessible only to authorized persons until the time of unblinding. All products were labelled with identical labels apart from a unique randomisation number.</p>",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015875/full","10.1002/14651858.CD015875","10::overall","CD015875_data","direction_only",FALSE,FALSE,FALSE,-0.209872273568972,0.00279805291213443,-1.13270295225696,0.712958405119019,-0.0879210434048784,0.0935171492291473,TRUE,FALSE
5,10,"Mean arterial pressure (MAP) (mmHg) (0 to 19 years)",NA,NA,"SUBGROUP_AND_OVERALL","Sanchis-Chorda 2019",2019,NA,NA,-0.9,7.289663915,NA,23,0.85,7.25,NA,25,NA,NA,100,-1.75,-5.867277,2.367277,NA,"Some concerns","<p>There was no information about whether the allocation was being concealed until participants were enrolled and assigned to interventions.</p>",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015875/full","10.1002/14651858.CD015875","10::overall","CD015875_data","direction_only",FALSE,FALSE,FALSE,-0.209872273568972,0.00279805291213443,-1.13270295225696,0.712958405119019,-0.0879210434048784,0.0935171492291473,TRUE,FALSE
6,10,"HOMA-IR (0 to 19 years)",NA,NA,"SUBGROUP_AND_OVERALL","Kilic Yildirim 2023",2023,NA,NA,-0.65,2.645751311,NA,28,-0.68,2.54950975,NA,26,NA,NA,100,0.03,-1.355904,1.415904,NA,"Low risk","<p>Patients were divided in 2 groups by a computer-generated randomisation sequence which assigned participants in a 1:1 allocation ratio to treatment with synbiotic or placebo with blocks of 8, blinding the study team, patients and their relatives. The second group was given a placebo consisting of a similar sachet with shape, taste, and smeel identical to the synbiotic sachet for 12 weeks.</p>",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015875/full","10.1002/14651858.CD015875","10::overall","CD015875_data","direction_only",FALSE,FALSE,FALSE,-0.209872273568972,0.00279805291213443,-1.13270295225696,0.712958405119019,-0.0879210434048784,0.0935171492291473,TRUE,FALSE
7,10,"Triglycerides (mg/dL) (0 to 19 years)",NA,NA,"SUBGROUP_AND_OVERALL","Vega-Cárdenas 2023",2023,NA,NA,23.62962963,104.2901,NA,27,8.6,78.42448597,NA,10,NA,NA,100,15.02963,-47.501225,77.560485,NA,"Low risk","<p>The randomisation list was generated by a person not directly involved in the study using the random package in R software. The enrolled children were randomised to the three groups in a 1:1:1 ratio stratified by age at the time of study enrolment. An independent statistician without contact with the participants had access to the randomisation list to label the study products. The trial products had a similar appearance and were provided with identical labelling.</p>",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015875/full","10.1002/14651858.CD015875","10::overall","CD015875_data","direction_only",FALSE,FALSE,FALSE,-0.209872273568972,0.00279805291213443,-1.13270295225696,0.712958405119019,-0.0879210434048784,0.0935171492291473,TRUE,FALSE
8,10,"LDL cholesterol (mg/dL) (0 to 19 years)",NA,NA,"SUBGROUP_AND_OVERALL","Coppola 2022",2020,NA,NA,-13.63,16.25786886,NA,23,-12.96,20.1,NA,25,NA,NA,100,-0.67,-10.976597,9.636597,NA,"Low risk","<p>A central randomisation was used to allocate children in a 1:1 ratio into treatment groups. The randomisation list was generated applying the ralloc command with block sizes of 2 (Stata, version 14.2, StataCorp LLC). The packaging, color, and weight of the butyrate and placebo capsules were identical. The capsules were provided in sequentially numbered boxes, protected by opaque and sealed envelopes of identical appearance, and prepared by independent pharmacy according to the randomisation list.</p>",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015875/full","10.1002/14651858.CD015875","10::overall","CD015875_data","direction_only",FALSE,FALSE,FALSE,-0.209872273568972,0.00279805291213443,-1.13270295225696,0.712958405119019,-0.0879210434048784,0.0935171492291473,TRUE,FALSE
